https://www.selleckchem.com/pr....oducts/blasticidin-s
Background Recently, we reported that the level of lathosterol, a cholesterol synthesis marker, was suppressed after 1 month of treatment with anagliptin, a dipeptidyl peptidase-4 inhibitor. In this study, we administered either anagliptin or miglitol, an alpha-glucosidase inhibitor, for 3 months in patients with type 2 diabetes and compared the lipid-lowering effects of anagliptin with those of miglitol. Methods This study was a 12-week, open-label, prospective, randomized, parallel-group comparison trial. Fifty-two patients
Like
Comment
Share
